Trademark: 75639982
Word
TEMODAR
Status
Registered
Status Code
800
Status Date
Thursday, November 5, 2020
Serial Number
75639982
Registration Number
2378174
Registration Date
Tuesday, August 15, 2000
Mark Type
1000
Filing Date
Friday, February 12, 1999
Published for Opposition
Tuesday, November 23, 1999

Trademark Owner History

Classifications
5 alkylating cytotoxic agent for the treatment of various types of cancer

Trademark Events
Jun 29, 2022
Automatic Update Of Assignment Of Ownership
Jun 10, 2021
Teas Change Of Correspondence Received
Jun 10, 2021
Teas Withdrawal Of Attorney Received-Firm Retains
Jun 10, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 10, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 5, 2020
Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed
Nov 5, 2020
Registered And Renewed (Second Renewal - 10 Yrs)
Nov 5, 2020
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Sep 21, 2020
Case Assigned To Post Registration Paralegal
Aug 11, 2020
Teas Section 8 & 9 Received
Aug 15, 2019
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Jun 13, 2012
Automatic Update Of Assignment Of Ownership
Aug 18, 2010
Registered And Renewed (First Renewal - 10 Yrs)
Aug 18, 2010
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Aug 16, 2010
Case Assigned To Post Registration Paralegal
Aug 5, 2010
Teas Section 8 & 9 Received
Oct 20, 2006
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Aug 11, 2006
Registered - Sec. 8 (6-Yr) & Sec. 15 Filed
Aug 11, 2006
Teas Section 8 & 15 Received
Feb 27, 2006
Case File In Ticrs
Feb 24, 2006
Case File In Ticrs
Feb 24, 2006
Case File In Ticrs
Aug 15, 2000
Registered-Principal Register
May 26, 2000
Allowed Principal Register - Sou Accepted
May 22, 2000
Assigned To Examiner
May 18, 2000
Statement Of Use Processing Complete
Apr 7, 2000
Use Amendment Filed
Feb 15, 2000
Noa Mailed - Sou Required From Applicant
Nov 23, 1999
Published For Opposition
Oct 22, 1999
Notice Of Publication
Aug 3, 1999
Approved For Pub - Principal Register
Jul 20, 1999
Assigned To Examiner

Trademark Alertz updated from USPTO on 2030-01-24